|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/0775 | |
| A61K 35/28 | |||
| A61P 13/12 | |||
| A61P 9/00 | |||
| A61K 9/00 | |||
| A61K 31/7028 |
| (11) | Patento numeris | 2931876 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13862555.3 |
| Europos patento paraiškos padavimo data | 2013-12-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/AU2013/001452 |
| Data | 2013-12-12 |
| (87) | Numeris | WO 2014/089623 |
| Data | 2014-06-19 |
| (30) | Numeris | Data | Šalis |
| 201261736361 P | 2012-12-12 | US |
| (72) |
KIMPTON, Wayne Gregory, AU
BAILEY, Simon Reeves, AU
ITESCU, Silviu, AU
GHOSH, Peter, AU
|
| (73) |
Mesoblast, Inc.,
505 Fifth Avenue Third Floor, New York, NY 10017,
US
|
| (54) | TREATMENT OF DISEASES OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION |
| TREATMENT OF DISEASES OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION |